RYANRYAN SPECIALTY HOLDINGS, INC.

NYSE ryansg.com


$ 51.49 $ -0.01 (-0.02 %)    

Monday, 06-May-2024 15:59:56 EDT
QQQ $ 439.97 $ 4.77 (1.1 %)
DIA $ 388.40 $ 1.68 (0.43 %)
SPY $ 516.34 $ 5.28 (1.03 %)
TLT $ 90.16 $ 0.35 (0.39 %)
GLD $ 215.21 $ 2.24 (1.05 %)
$ 51.49
$ 51.02
$ 0.00 x 0
$ 0.00 x 0
$ 50.16 - $ 51.54
$ 39.19 - $ 56.52
782,990
na
13.9B
$ 0.27
$ 215.77
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-04-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-16-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 09-02-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wolfe-research-downgrades-ryan-specialty-hldgs-to-peer-perform

Wolfe Research analyst Bill Carcache downgrades Ryan Specialty Hldgs (NYSE:RYAN) from Outperform to Peer Perform.

 ryan-specialty-sees-organic-revenue-growth-rate-guidance-for-full-year-2024-is-between-12514

Full Year 2024 Outlook*The Company is maintaining its full year 2024 outlook for Organic Revenue Growth Rate (under the legacy ...

 ryan-specialty-hldgs-q1-adj-035-inline-sales-55205m-beat-54914m-estimate

Ryan Specialty Hldgs (NYSE:RYAN) reported quarterly earnings of $0.35 per share which met the analyst consensus estimate. This ...

 jmp-securities-reiterates-market-perform-on-ryan-specialty-hldgs

JMP Securities analyst Matthew Carletti reiterates Ryan Specialty Hldgs (NYSE:RYAN) with a Market Perform.

 wells-fargo-maintains-overweight-on-ryan-specialty-hldgs-raises-price-target-to-58

Wells Fargo analyst Elyse Greenspan maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Overweight and raises the price target...

 keefe-bruyette--woods-maintains-outperform-on-ryan-specialty-hldgs-raises-price-target-to-62

Keefe, Bruyette & Woods analyst Meyer Shields maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Outperform and raises th...

 jp-morgan-maintains-underweight-on-ryan-specialty-hldgs-raises-price-target-to-49

JP Morgan analyst Jimmy Bhullar maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Underweight and raises the price target fr...

 citigroup-maintains-neutral-on-ryan-specialty-hldgs-raises-price-target-to-52

Citigroup analyst Michael Ward maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Neutral and raises the price target from $4...

 keefe-bruyette--woods-maintains-outperform-on-ryan-specialty-hldgs-raises-price-target-to-56

Keefe, Bruyette & Woods analyst Meyer Shields maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Outperform and raises th...

 jp-morgan-maintains-underweight-on-ryan-specialty-hldgs-raises-price-target-to-47

JP Morgan analyst Jimmy Bhullar maintains Ryan Specialty Hldgs (NYSE:RYAN) with a Underweight and raises the price target fr...

 ryan-specialty-hldgs-q4-2023-adj-eps-035-beats-034-estimate-sales-53290m-beat-52297m-estimate

Ryan Specialty Hldgs (NYSE:RYAN) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0...

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 ryan-specialty-signs-definitive-agreement-to-acquire-castel-underwriting-agencies-terms-of-the-transaction-were-not-disclosed-the-acquisition-is-expected-to-close-during-the-first-half-of-2024

Ryan Specialty (NYSE:RYAN), a leading international specialty insurance firm, is pleased to announce it has signed a definitive...

 six-flags-entertainment-to-rally-around-35-here-are-10-top-analyst-forecasts-for-monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION